Corporate News     14-Dec-12
Marksans Pharma allots equity shares
On conversion of warrants
The board of Marksans Pharma in its meeting on 14 December 2012 has issued and allotted 1,75,00,000 equity shares of Re 1 each at a price of Rs 2.56 per equity share to Mark Saldanha (promoter group) on conversion of warrants issued under preferential allotment basis.
Previous News
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  Marksans Pharma gets EIR from USFDA for Goa facility
 ( Hot Pursuit - 20-Aug-24   14:48 )
  Marksans Pharma to convene AGM
 ( Corporate News - 20-Aug-24   10:46 )
  Marksans Pharma jumps after Q3 PAT climbs 34% YoY to Rs 83 cr
 ( Hot Pursuit - 13-Feb-24   15:41 )
  Marksans Pharma consolidated net profit declines 3.87% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:22 )
  Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter
 ( Results - Announcements 13-Feb-24   16:31 )
  Marksans Pharma standalone net profit declines 33.55% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:23 )
  Marksans Pharma's Verna unit successfully completes USFDA inspection
 ( Corporate News - 20-Aug-24   14:37 )
  Marksans Pharma gets UK MHRA approval for Fluoxetine oral solution
 ( Hot Pursuit - 23-Jan-23   13:30 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 18-May-23   15:47 )
  Marksans Pharma consolidated net profit declines 18.10% in the December 2021 quarter
 ( Results - Announcements 11-Feb-22   14:46 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top